Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum β-lactamase inhibitors:: Evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods

被引:40
作者
Venkatesan, Aranapakam M.
Agarwal, Atul
Abe, Takao
Ushirogochi, Hideki
Yamamura, Itsuka
Ado, Mihira
Tsuyoshi, Takasaki
Dos Santos, Osvaldo
Gu, Yansong
Sum, Fuk-Wah
Li, Zhong
Francisco, Gerry
Lin, Yang-I
Petersen, Peter J.
Yang, Youjun
Kumagai, Toshio
Weiss, William J.
Shlaes, David M.
Knox, James R.
Mansour, Tarek S.
机构
[1] Wyeth Res, Chem & Screening Sci, Dept Infect Dis & Biol Technol, Pearl River, NY 10965 USA
[2] Univ Connecticut, Storrs, CT 06269 USA
关键词
D O I
10.1021/jm060021p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design and synthesis of a series of 6-methylidene penems containing [6,5]-fused bicycles (thiophene, imidazole, or pyrazle-fused system) as novel class A, B, and C beta-lactamase inhibitors is described. These penems proved to be potent inhibitors of the TEM-1 (class A) and AmpC (class C) beta-lactamases and less so against the class B metallo-beta-lactamase CcrA. Their in vitro and in vivo activities in combination with piperacillin are discussed. On the basis of the crystallographic structures of a serine-bound reaction intermediate of 2 with SHV-1 (class A) and GC1 (class C) enzymes, compounds 14a-1 were designed and synthesized. Penems are proposed to form a seven-membered 1,4 thiazepine ring in both class A and C beta-lactamases. The interaction energy calculation for the enzyme-bound intermediates favor the formation of the C7 R enantiomer over the S enantiomer of the 1,4-thiazepine in both beta-lactamases, which is consistent with those obtained from the crystal structure of 2 with SHV-1 and GC1.
引用
收藏
页码:4623 / 4637
页数:15
相关论文
共 46 条
[1]   A novel, mild, and facile method to prepare 6-methylidene penem derivatives [J].
Abe, T ;
Sato, C ;
Ushirogochi, H ;
Sato, K ;
Takasaki, T ;
Isoda, T ;
Mihira, A ;
Yamamura, I ;
Hayashi, K ;
Kumagai, T ;
Tamai, S ;
Shiro, M ;
Venkatesan, AM ;
Mansour, TS .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (18) :5850-5860
[2]  
Abe T., 2003, WO Patent, Patent No. [WO 2003093277 A1, 2003093277]
[3]  
ADACHI H, 1990, J BIOL CHEM, V265, P3992
[4]  
[Anonymous], ANTIBIOTICS LABORATO
[5]   6-(SUBSTITUTED METHYLENE)PENEMS, POTENT BROAD-SPECTRUM INHIBITORS OF BACTERIAL BETA-LACTAMASE .3. STRUCTURE-ACTIVITY-RELATIONSHIPS OF THE 5-MEMBERED HETEROCYCLIC-DERIVATIVES [J].
BENNETT, I ;
BROOM, NJP ;
BRUTON, G ;
CALVERT, S ;
CLARKE, BP ;
COLEMAN, K ;
EDMONDSON, R ;
EDWARDS, P ;
JONES, D ;
OSBORNE, NF ;
WALKER, G .
JOURNAL OF ANTIBIOTICS, 1991, 44 (03) :331-337
[6]   6-(SUBSTITUTED METHYLENE)PENEMS, POTENT BROAD-SPECTRUM INHIBITORS OF BACTERIAL BETA-LACTAMASE .5. CHIRAL 1,2,3-TRIAZOLYL DERIVATIVES [J].
BENNETT, IS ;
BROOKS, G ;
BROOM, NJP ;
CALVERT, SH ;
COLEMAN, K ;
FRANCOIS, I .
JOURNAL OF ANTIBIOTICS, 1991, 44 (09) :969-978
[7]  
Bitha P, 1999, BIOORG MED CHEM LETT, V9, P991, DOI 10.1016/S0960-894X(99)00106-7
[8]   6-(1-hydroxyalkyl)penam sulfone derivatives as inhibitors of class A and class C β-lactamases -: II. [J].
Bitha, P ;
Li, Z ;
Francisco, GD ;
Yang, YJ ;
Petersen, PJ ;
Lenoy, E ;
Lin, YI .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (07) :997-1002
[9]   In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor [J].
Bonnefoy, A ;
Dupuis-Hamelin, C ;
Steier, V ;
Delachaume, C ;
Seys, C ;
Stachyra, T ;
Fairley, M ;
Guitton, M ;
Lampilas, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (02) :410-417
[10]  
Bou German, 2005, Current Medicinal Chemistry - Anti-Infective Agents, V4, P219, DOI 10.2174/1568012054368100